Revised assessment of response and long-term discontinuation rates among 111 patients with myelofibrosis treated with momelotinib or ruxolitinib

R. A. Abdelrahman, Kebede Begna, A. Al-Kali, William Hogan, Mark R Litzow, Ayalew Tefferi

Research output: Contribution to journalArticle

9 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)498-500
Number of pages3
JournalLeukemia
Volume29
Issue number2
DOIs
StatePublished - Feb 7 2015

Fingerprint

Benzamides
Pyrazoles
Janus Kinase 2
Remission Induction
Pyrimidines
Primary Myelofibrosis
N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide
INCB018424

ASJC Scopus subject areas

  • Hematology
  • Cancer Research
  • Anesthesiology and Pain Medicine
  • Medicine(all)

Cite this

@article{592561791e084188be23cfd7dbb29d4e,
title = "Revised assessment of response and long-term discontinuation rates among 111 patients with myelofibrosis treated with momelotinib or ruxolitinib",
author = "Abdelrahman, {R. A.} and Kebede Begna and A. Al-Kali and William Hogan and Litzow, {Mark R} and Ayalew Tefferi",
year = "2015",
month = "2",
day = "7",
doi = "10.1038/leu.2014.286",
language = "English (US)",
volume = "29",
pages = "498--500",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - Revised assessment of response and long-term discontinuation rates among 111 patients with myelofibrosis treated with momelotinib or ruxolitinib

AU - Abdelrahman, R. A.

AU - Begna, Kebede

AU - Al-Kali, A.

AU - Hogan, William

AU - Litzow, Mark R

AU - Tefferi, Ayalew

PY - 2015/2/7

Y1 - 2015/2/7

UR - http://www.scopus.com/inward/record.url?scp=84922465797&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922465797&partnerID=8YFLogxK

U2 - 10.1038/leu.2014.286

DO - 10.1038/leu.2014.286

M3 - Article

C2 - 25252872

AN - SCOPUS:84922465797

VL - 29

SP - 498

EP - 500

JO - Leukemia

JF - Leukemia

SN - 0887-6924

IS - 2

ER -